Long-term Oxygen Treatment Trial

NCT00692198 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

738

Enrollment

NIH

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Supplemental oxygen therapy

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Collaborators

[object Object]